Asthma control parameters in children on home administration of biologics
| Pre-COVID-19 | Post-COVID-19 | Significance | |
| FEV1 % predicted (median, IQR) | 89% (77%–95%) (n=14) | 89% (82%–102%) (4-month data n=10, 3-month data n=14) | ns |
| ACT (median, IQR) | 18 (13–22) (n=14) | 23 (19–24) (4-month data n=13, 3-month data n=14) | p=0.0005 |
| PAQLQ (median, range) | 6.4 (4.6–6.8) (2-month data n=13, 1-month data n=14) | 6.6 (6.3–6.8) (4-month data n=13, 3-month data n=14) | p=0.003 |
| OCS (median n=14) | 0 | 0 | – |
| GP/A&E visit (median n=14) | 0 | 0 | – |
| Hospital admission (median n=14) | 0 | 0 | – |
ACT, Asthma Control Test; A&E, accident and emergency; FEV1, forced expiratory volume in one second ; GP, general practice; IQR, Inter quartile range; ns, not significant; OCS, oral corticosteroids; PAQLQ, Paediatric Asthma Quality of Life Questionnaire.